Literature DB >> 25527780

Caveolin-1 prevents sustained angiotensin II-induced resistance artery constriction and obesity-induced high blood pressure.

Istvan Czikora1, Attila Feher1, Rudolf Lucas1, David J R Fulton1, Zsolt Bagi2.   

Abstract

The type 1 angiotensin II (ANG II) receptor (AT1R) undergoes internalization following stimulation by ANG II. Internalization reduces cell surface AT1Rs, and it is required for AT1R resensitization. In this process AT1R may interact with caveolin-1 (Cav1), the main scaffolding protein of caveolae. We hypothesized that the interaction between Cav1 and AT1R delays AT1R resensitization and thereby prevents sustained ANG II-induced resistance artery (RA) constriction under normal conditions and in experimental obesity. In rat and mouse skeletal muscle RA (diameter: ∼90-120 μm) ANG II-induced constrictions were reduced upon repeated (30-min apart) administrations. Upon disruption of caveolae with methyl-β-cyclodextrin or in RA of Cav1 knockout mice, repeated ANG II applications resulted in essentially maintained constrictions. In vascular smooth muscle cells, AT1R interacted with Cav1, and the degree of cell surface interactions was reduced by long-term (15-min), but not short-term (2-min), exposure to ANG II. When Cav1 was silenced, the amount of membrane-associated AT1R was significantly reduced by a short-term ANG II exposure. Moreover, Cav1 knockout mice fed a high-fat diet exhibited augmented and sustained RA constriction to ANG II and had elevated systemic blood pressure, when compared with normal or high-fat fed wild-type mice. Thus, Cav1, through a direct interaction, delays internalization and subsequent resensitization of AT1R. We suggest that this mechanism prevents sustained ANG II-induced RA constriction and elevated systemic blood pressure in diet-induced obesity.
Copyright © 2015 the American Physiological Society.

Entities:  

Keywords:  angiotensin receptor; arteriole; caveolae; hypertension; obesity; trafficking

Mesh:

Substances:

Year:  2014        PMID: 25527780      PMCID: PMC4346763          DOI: 10.1152/ajpheart.00649.2014

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  43 in total

Review 1.  Caveolin-dependent angiotensin II type 1 receptor signaling in vascular smooth muscle.

Authors:  Masuko Ushio-Fukai; R Wayne Alexander
Journal:  Hypertension       Date:  2006-10-02       Impact factor: 10.190

2.  Caveolin-1 limits the contribution of BK(Ca) channel to EDHF-mediated arteriolar dilation: implications in diet-induced obesity.

Authors:  Attila Feher; Ibolya Rutkai; Timea Beleznai; Zoltan Ungvari; Anna Csiszar; Istvan Edes; Zsolt Bagi
Journal:  Cardiovasc Res       Date:  2010-03-17       Impact factor: 10.787

Review 3.  G protein-coupled receptors. III. New roles for receptor kinases and beta-arrestins in receptor signaling and desensitization.

Authors:  R J Lefkowitz
Journal:  J Biol Chem       Date:  1998-07-24       Impact factor: 5.157

4.  Regulation of coronary arterial BK channels by caveolae-mediated angiotensin II signaling in diabetes mellitus.

Authors:  Tong Lu; Dai-Min Zhang; Xiao-Li Wang; Tongrong He; Ru-Xing Wang; Qiang Chai; Zvonimir S Katusic; Hon-Chi Lee
Journal:  Circ Res       Date:  2010-02-18       Impact factor: 17.367

5.  High intraluminal pressure via H2O2 upregulates arteriolar constrictions to angiotensin II by increasing the functional availability of AT1 receptors.

Authors:  Zsolt Bagi; Nora Erdei; Akos Koller
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-06-20       Impact factor: 4.733

6.  Control of blood pressure variability in caveolin-1-deficient mice: role of nitric oxide identified in vivo through spectral analysis.

Authors:  Fanny Desjardins; Irina Lobysheva; Michel Pelat; Bernard Gallez; Olivier Feron; Chantal Dessy; Jean-Luc Balligand
Journal:  Cardiovasc Res       Date:  2008-03-18       Impact factor: 10.787

Review 7.  Mechanisms of coronary microvascular adaptation to obesity.

Authors:  Zsolt Bagi
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-06-17       Impact factor: 3.619

8.  Caveolin-1 ablation reduces the adverse cardiovascular effects of N-omega-nitro-L-arginine methyl ester and angiotensin II.

Authors:  Luminita H Pojoga; Jose R Romero; Tham M Yao; Paul Loutraris; Vincent Ricchiuti; Patricia Coutinho; Christine Guo; Nathalie Lapointe; James R Stone; Gail K Adler; Gordon H Williams
Journal:  Endocrinology       Date:  2010-01-22       Impact factor: 4.736

9.  Cyclooxygenase products do not modulate angiotensin II-induced contractions of human chorionic plate arteries.

Authors:  G Sorokin; N M Grant; B M Egan; J H Lombard
Journal:  Am J Obstet Gynecol       Date:  1992-07       Impact factor: 8.661

10.  Angiotensin II type 1 receptor: relationship with caveolae and caveolin after initial agonist stimulation.

Authors:  N Ishizaka; K K Griendling; B Lassègue; R W Alexander
Journal:  Hypertension       Date:  1998-09       Impact factor: 10.190

View more
  9 in total

1.  Role of Adipose Tissue Endothelial ADAM17 in Age-Related Coronary Microvascular Dysfunction.

Authors:  Huijuan Dou; Attila Feher; Alec C Davila; Maritza J Romero; Vijay S Patel; Vinayak M Kamath; Monika Beck Gooz; R Daniel Rudic; Rudolf Lucas; David J Fulton; Neal L Weintraub; Zsolt Bagi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-05-04       Impact factor: 8.311

2.  Caveolin-1 Deletion Prevents Hypertensive Vascular Remodeling Induced by Angiotensin II.

Authors:  Steven J Forrester; Katherine J Elliott; Tatsuo Kawai; Takashi Obama; Michael J Boyer; Kyle J Preston; Zhen Yan; Satoru Eguchi; Victor Rizzo
Journal:  Hypertension       Date:  2016-11-28       Impact factor: 10.190

3.  Brain Renin-Angiotensin System Blockade Attenuates Methamphetamine-Induced Hyperlocomotion and Neurotoxicity.

Authors:  Linhong Jiang; Ruiming Zhu; Qian Bu; Yan Li; Xue Shao; Hui Gu; Jueying Kong; Li Luo; Hailei Long; Wei Guo; Jingwei Tian; Yinglan Zhao; Xiaobo Cen
Journal:  Neurotherapeutics       Date:  2018-04       Impact factor: 7.620

Review 4.  The Evaluation and Therapeutic Management of Hypertension in the Transplant Patient.

Authors:  Beje Thomas; Matthew R Weir
Journal:  Curr Cardiol Rep       Date:  2015-11       Impact factor: 2.931

Review 5.  Versatile Functions of Caveolin-1 in Aging-related Diseases.

Authors:  Kim Cuc Thi Nguyen; Kyung A Cho
Journal:  Chonnam Med J       Date:  2017-01-25

6.  Role of Caveolae in the Development of Microvascular Dysfunction and Hyperglycemia in Type 2 Diabetes.

Authors:  Yanna Tian; Katie Anne Fopiano; Vijay S Patel; Attila Feher; Zsolt Bagi
Journal:  Front Physiol       Date:  2022-02-18       Impact factor: 4.566

7.  Walnut supplementation after fructose-rich diet is associated with a beneficial fatty acid ratio and increased ACE2 expression in the rat heart.

Authors:  Maja Bošković; Maja Živković; Goran Koricanac; Snezana Tepavcevic; Manja Zec; Jasmina Debeljak-Martacic; Aleksandra Stanković
Journal:  Front Physiol       Date:  2022-09-21       Impact factor: 4.755

8.  A Common Variation in the Caveolin 1 Gene Is Associated with High Serum Triglycerides and Metabolic Syndrome in an Admixed Latin American Population.

Authors:  Gustavo Mora-García; Doris Gómez-Camargo; Ángelo Alario; Claudio Gómez-Alegría
Journal:  Metab Syndr Relat Disord       Date:  2018-05-15       Impact factor: 1.894

9.  Orthogonal Peptide-Templated Labeling Elucidates Lateral ETA R/ETB R Proximity and Reveals Altered Downstream Signaling.

Authors:  Philipp Wolf; Alexander Mohr; Georgina Gavins; Victoria Behr; Karin Mörl; Oliver Seitz; Annette G Beck-Sickinger
Journal:  Chembiochem       Date:  2021-10-26       Impact factor: 3.461

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.